Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

ALC

Alcon (ALC)

Alcon Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:ALC
DateHeureSourceTitreSymboleSociété
07/04/202423h59Business WireAlcon Publishes Agenda for 2024 Annual General MeetingNYSE:ALCAlcon Inc
12/03/202409h30Business WireAlcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in IndiaNYSE:ALCAlcon Inc
06/03/202415h55Business WireVivity, the World’s Leading EDOF IOL, Reaches One Million MilestoneNYSE:ALCAlcon Inc
06/03/202415h55Business WireVivity, la LIO à profondeur focale accrue première au monde, atteint un million d’implantsNYSE:ALCAlcon Inc
02/03/202400h44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ALCAlcon Inc
27/02/202422h30Business WireAlcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023NYSE:ALCAlcon Inc
26/02/202413h00Business WireAlgoma Central Corporation Reports Financial Results for Fiscal 2023NYSE:ALCAlcon Inc
12/02/202422h22Business WireAlgoma Central Corporation to Issue Fiscal 2023 Financial Results on February 26, 2024NYSE:ALCAlcon Inc
01/02/202419h04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ALCAlcon Inc
01/02/202415h02Business WireAlcon Canada lance les lentilles cornéennes TOTAL30 Multifocal pour les patients porteurs de lentilles réutilisables atteints de presbytieNYSE:ALCAlcon Inc
18/01/202414h54Business WireAlgoma Central Corporation continues to grow product tanker business with the acquisition of two additional vesselsNYSE:ALCAlcon Inc
10/01/202410h12Dow Jones NewsAlcon Shares Rise After Dry-Eye Care Drug Shows Promising ResultsNYSE:ALCAlcon Inc
09/01/202423h20Dow Jones NewsAlcon Reports Results for Dry-Eye-Treatment TrialsNYSE:ALCAlcon Inc
09/01/202422h30Business WireAlcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry EyeNYSE:ALCAlcon Inc
05/01/202414h00GlobeNewswire Inc.Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial ArrangementsNYSE:ALCAlcon Inc
27/12/202315h01Business WireAlcon to Present at 2024 Annual J.P. Morgan Healthcare ConferenceNYSE:ALCAlcon Inc
15/11/202317h08Dow Jones NewsAlcon Down Over 5%, On Track for Largest Percent Decrease Since May 2022 -- Data TalkNYSE:ALCAlcon Inc
15/11/202312h11Dow Jones NewsAlcon's Swiss Shares Drop After Guidance Narrowed to Lower End of RangeNYSE:ALCAlcon Inc
14/11/202322h30Business WireAlcon Reports Third Quarter 2023 ResultsNYSE:ALCAlcon Inc
08/11/202315h03Business WireAlcon Canada lance Clareon Vivity, sa plus récente avancée en matière de LIO pour la correction de la presbytieNYSE:ALCAlcon Inc
03/11/202320h00Business WireAlgoma Central Corporation Reports Financial Performance for the 2023 Third QuarterNYSE:ALCAlcon Inc
30/10/202314h01Business WireAlcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023NYSE:ALCAlcon Inc
27/10/202313h00Business WireAlgoma Central Corporation to Issue Third Quarter 2023 Financial Results on November 3, 2023NYSE:ALCAlcon Inc
10/10/202314h01Business WireAlcon Launches TOTAL30 Multifocal Contact Lenses for Patients with PresbyopiaNYSE:ALCAlcon Inc
14/09/202313h00Business WireAlgoma Central Corporation and Furetank Co-Order Two Additional NewbuildsNYSE:ALCAlcon Inc
09/09/202307h01Business WireCataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle DependenceNYSE:ALCAlcon Inc
06/09/202322h30Business WireAlcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical TeamsNYSE:ALCAlcon Inc
15/08/202322h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:ALCAlcon Inc
15/08/202322h30Business WireAlcon Reports Second Quarter 2023 ResultsNYSE:ALCAlcon Inc
04/08/202313h00Business WireAlgoma Central Corporation Reports Financial Performance for the 2023 Second QuarterNYSE:ALCAlcon Inc
 Showing the most relevant articles for your search:NYSE:ALC